| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1539 | 2019 |
| EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ... European journal of neurology 20 (1), 16-34, 2013 | 624 | 2013 |
| EAN consensus review on prevention, diagnosis and management of tick‐borne encephalitis P Taba, E Schmutzhard, P Forsberg, I Lutsar, U Ljøstad, Å Mygland, ... European journal of neurology 24 (10), 1214-e61, 2017 | 212 | 2017 |
| Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ... Brain 137 (9), 2480-2492, 2014 | 209 | 2014 |
| Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms L Kadastik-Eerme, M Rosenthal, T Paju, M Muldmaa, P Taba Health and quality of life outcomes 13, 1-8, 2015 | 153 | 2015 |
| The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection E Moro, A Priori, E Beghi, R Helbok, L Campiglio, CL Bassetti, E Bianchi, ... European journal of neurology 27 (9), 1727-1737, 2020 | 124 | 2020 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 116 | 2021 |
| Patient education in Parkinson's disease: formative evaluation of a standardized programme in seven European countries M Macht, C Gerlich, H Ellgring, M Schradi, ÀB Rusiñol, M Crespo, A Prats, ... Patient education and counseling 65 (2), 245-252, 2007 | 109 | 2007 |
| A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details M Romoli, I Jelcic, R Bernard‐Valnet, D García Azorín, L Mancinelli, ... European journal of neurology 27 (9), 1712-1726, 2020 | 106 | 2020 |
| Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia P Taba, M Rosenthal, J Habicht, H Tarien, M Mathiesen, S Hill, L Bero BMC health services research 12, 1-7, 2012 | 106 | 2012 |
| Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration M Skorvanek, P Martinez‐Martin, N Kovacs, M Rodriguez‐Violante, ... Movement disorders clinical practice 4 (4), 536-544, 2017 | 105 | 2017 |
| Leg-extension strength and chair-rise performance in elderly women with Parkinson’s disease M Pääsuke, J Ereline, H Gapeyeva, K Joost, K Mõttus, P Taba Journal of Aging and Physical Activity 12 (4), 511-524, 2004 | 102 | 2004 |
| Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ... npj Parkinson's Disease 5 (1), 8, 2019 | 99 | 2019 |
| Neurosyphilis H Gonzalez, IJ Koralnik, CM Marra Seminars in neurology 39 (04), 448-455, 2019 | 97 | 2019 |
| Manganese-induced parkinsonism due to ephedrone abuse K Sikk, S Haldre, SM Aquilonius, P Taba Parkinson’s Disease 2011, 2011 | 94 | 2011 |
| Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease G Liu, J Peng, Z Liao, JJ Locascio, JC Corvol, F Zhu, X Dong, ... Nature genetics 53 (6), 787-793, 2021 | 93 | 2021 |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten npj Parkinson's Disease 5 (1), 6, 2019 | 91 | 2019 |
| Irreversible motor impairment in young addicts–ephedrone, manganism or both? K Sikk, P Taba, S Haldre, J Bergquist, D Nyholm, G Zjablov, T Asser, ... Acta Neurologica Scandinavica 115 (6), 385-389, 2007 | 89 | 2007 |
| European academy of neurology/movement disorder society‐European section guideline on the treatment of Parkinson's disease: I. Invasive therapies G Deuschl, A Antonini, J Costa, K Śmiłowska, D Berg, JC Corvol, ... European journal of neurology 29 (9), 2580-2595, 2022 | 83 | 2022 |
| Psychostimulants and movement disorders A Asser, P Taba Frontiers in neurology 6, 127637, 2015 | 80 | 2015 |
